A study by researchers at Thomas Jefferson University and Sidney Kimmel Cancer Center – Jefferson Health demonstrates that although Black patients are now more likely to receive the most effective treatment in non-small cell lung cancer than a decade ago, disparities persist.
New research led by Friends of Cancer Research demonstrates that decreases in circulating tumor DNA after initiation of treatment are associated with improved overall survival in patients with advanced non-small cell lung cancer treated with immunotherapy or chemotherapy.
